Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 25, 2022
Clinician attitudes and practices on pregnancy planning and care in cystic fibrosisKristina Montemayor, Traci M Kazmerski, Kristin A Riekert, et al.Clinics in Chest Medicine|August 6, 2021
Challenges Faced by Women with Cystic FibrosisRaksha Jain, Traci M Kazmerski, Moira L Aitken, et al.Infection and Immunity|August 9, 2017
17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor AntagonismShadaan Abid, ShangKui Xie, Moumita Bose, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 20, 2020
Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatmentE Emily Harruff, Jonathan Kil, Maria Gabriela Tupayachi Ortiz, et al.Annals of the American Thoracic Society|April 25, 2026
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United StatesGeorgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, et al.American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.American Journal of Respiratory and Critical Care Medicine|September 5, 2024
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human TrialJane C Davies, Deepika Polineni, A Christopher Boyd, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 10, 2025
Real-world association between ivacaftor initiation and lung function variability: A registry studyRhonda D Szczesniak, Eleni-Rosalina Andrinopoulou, Hancheng Li, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 2, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary ExacerbationsNatalie E West, Valeria V Beckett, Raksha Jain, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 12, 2023
Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosisTraci M Kazmerski, Olivia M Stransky, Danielle R Lavage, et al.Pageof 11